+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Targeted Sequencing Market - Global Forecast 2026-2032- Product Image
Targeted Sequencing Market - Global Forecast 2026-2032- Product Image
New

Targeted Sequencing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924844
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The targeted sequencing market offers actionable pathways for healthcare and life science organizations to enhance diagnostic accuracy, streamline workflows, and achieve operational efficiency. Senior decision-makers navigating shifts in technology, procurement, and integration find targeted sequencing central to advancing clinical and research priorities.

Market Snapshot: Targeted Sequencing Market Overview

The Targeted Sequencing Market grew from USD 9.18 billion in 2025 to USD 11.10 billion in 2026 and is projected to reach USD 34.97 billion by 2032, reflecting a CAGR of 21.04%. The increasing need for advanced next-generation sequencing solutions across clinical, pharmaceutical, and research environments is driving this robust growth. Market demand is shaped by ongoing improvements in instrument throughput, reagent chemistries, and sophisticated bioinformatics tools, each contributing to greater precision, workflow adaptability, and reliable genomic data analysis. As targeted sequencing applications expand, organizations are seeking new approaches to integrate advanced solutions, streamline data management, and support evolving research and patient-care outcomes.

Scope & Segmentation

  • Product Types: Instruments—ranging from compact benchtop models to high-throughput sequencers—enable tailored analyses across lab types. Reagents and kits include amplicon-based, hybridization-based, and molecular inversion probe systems, supporting varied assay designs. Bioinformatics software and service providers deliver essential support for data interpretation, validation, and compliance.
  • Platform Methodologies: Amplicon sequencing integrates multiplex PCR and unique molecular index protocols for targeted variant detection. Hybrid capture technologies use bait-based and probe-based enrichment for comprehensive coverage of selected genomic regions. Molecular inversion probe strategies address precise use cases, balancing assay efficiency with flexibility.
  • End User Groups: Academic and research institutes focus on translational studies and custom genomic panels. Hospitals and diagnostics centers require validated, regulatory-compliant solutions for clinical adoption. Pharmaceutical and biotechnology companies demand scalable, robust platforms that support both research and commercialization imperatives.
  • Applications: Biomarker discovery underpins precision medicine development, while genetic disease testing drives clinical adoption. Infectious disease workflows, including pathogen detection and resistance profiling, continue to grow in diagnostic significance. Oncology panels support comprehensive profiling needs across the therapeutic continuum.
  • Regions Covered: The Americas, Europe, Middle East & Africa, and Asia-Pacific each exhibit unique regulatory, infrastructure, and reimbursement landscapes. For example, regulatory harmonization in Europe influences platform adoption, while rapidly expanding reimbursement mechanisms in Asia-Pacific shape operational expansion strategies.

Key Takeaways

  • Technological advancements across chemistry, instrumentation, and informatics are introducing more sensitive and clinically actionable targeted panels. Laboratories benefit from improved workflow reliability and better adaptation to rapidly changing research landscapes.
  • Operational strategies, particularly around platform and reagent selection, directly influence scalability, cost structures, and workflow customization—enabling leaders to optimize resource allocation in dynamic regulatory environments.
  • Partnerships between suppliers, software vendors, and service organizations reduce complexity across the sequencing value chain. These collaborations help streamline integration, accelerate time-to-result, and ensure long-term support ecosystems for stakeholders.
  • Regulatory shifts and reimbursement updates require ongoing investments in assay validation, reporting standardization, and market readiness. Developers aligning offerings with evolving clinical practice can address diverse compliance needs efficiently.
  • Segmented approaches—by product, platform, application, and end user—support differentiated go-to-market strategies. Leaders are leveraging segmentation tools to coordinate product development, channel distribution, and service initiatives for maximum alignment with modern market requirements.
  • Modular product architectures and validated workflows minimize implementation disruption. These approaches improve adoption, accelerate deployment, and help maintain service continuity across healthcare and research ecosystems.

Tariff Impact on Targeted Sequencing Programs

Tariffs affecting laboratory equipment and consumables introduce additional procurement and budgeting challenges for sequencing programs. Organizations are diversifying supplier portfolios, renegotiating contracts, and exploring domestic and regional manufacturing to maintain continuity and price stability. These factors impact logistics planning and lead times, prompting revised inventory management strategies. Design-for-cost initiatives—such as optimizing multiplexing protocols and limiting reagent consumption—are increasingly integrated into supply chain planning to safeguard operational resilience.

Methodology & Data Sources

This market report on targeted sequencing applies a mixed-methods approach, synthesizing peer-reviewed technical literature, regulatory insights, supply chain analysis, and expert interviews. Triangulation across assay chemistry, instrument performance claims, and documented vendor references ensures all findings are validated and relevant for actionable decision-making in clinical and research contexts.

Why This Report Matters

  • Presents actionable segmentation and in-depth industry insights, tailored to the needs of executive stakeholders responsible for market entry, technology selection, and operational scale-up.
  • Equips leadership teams to navigate ongoing policy shifts, optimize supplier and platform choices, and bolster continuity strategies for robust supply chains.
  • Supports alignment with shifting regulatory and reimbursement standards, accelerating product adoption and maintaining consistent performance improvements.

Conclusion

Targeted sequencing is establishing new standards for clinical and research workflows. Investment in versatile platforms, agile supply chains, and collaborative approaches positions organizations to drive better outcomes in precision medicine and sustain market growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Targeted Sequencing Market, by Product Type
8.1. Instruments
8.1.1. Benchtop Sequencers
8.1.2. High-Throughput Sequencers
8.2. Reagents & Kits
8.2.1. Amplicon-Based Kits
8.2.2. Hybridization-Based Kits
8.2.3. MIP-Based Kits
8.3. Software & Services
8.3.1. Bioinformatics Services
8.3.2. Data Analysis Software
9. Targeted Sequencing Market, by Platform
9.1. Amplicon Sequencing
9.1.1. Multiplex PCR
9.1.2. UMI-Based Sequencing
9.2. Hybrid Capture
9.2.1. Baits-Based Capture
9.2.2. Probe-Based Capture
9.3. Molecular Inversion Probes
9.3.1. MIP Probes For CNV Analysis
9.3.2. MIP Probes For SNP Detection
10. Targeted Sequencing Market, by End User
10.1. Academic & Research Institutes
10.2. Hospitals & Diagnostic Centers
10.2.1. Point-of-Care Laboratories
10.2.2. Reference Laboratories
10.3. Pharmaceutical & Biotechnology Companies
10.3.1. Clinical Research Organizations
10.3.2. Drug Discovery Units
11. Targeted Sequencing Market, by Application
11.1. Biomarker Discovery
11.1.1. Pharmacogenomic Biomarkers
11.1.2. Predictive Biomarkers
11.2. Genetic Diseases
11.2.1. Prenatal Testing
11.2.2. Rare Disease Diagnosis
11.3. Infectious Diseases
11.3.1. Antibiotic Resistance Testing
11.3.2. Pathogen Detection
11.4. Oncology
11.4.1. Diagnostics
11.4.2. Prognostics
11.4.3. Theranostics
12. Targeted Sequencing Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Targeted Sequencing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Targeted Sequencing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Targeted Sequencing Market
16. China Targeted Sequencing Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. 10x Genomics, Inc.
17.6. A-Alpha Bio, Inc.
17.7. Agilent Technologies, Inc.
17.8. Azenta Life Sciences
17.9. BGI Genomics Co., Ltd.
17.10. Bio-Rad Laboratories, Inc.
17.11. CD Genomics
17.12. DH Life Sciences, LLC
17.13. Element Biosciences
17.14. F. Hoffmann-La Roche Ltd.
17.15. Illumina, Inc.
17.16. LGC Limited
17.17. Macrogen, Inc.
17.18. MGI Tech Co., Ltd.
17.19. Oxford Nanopore Technologies PLC
17.20. Pacific Biosciences of California, Inc.
17.21. Paragon Genomics, Inc.
17.22. PerkinElmer, Inc.
17.23. Psomagen, Inc.
17.24. QIAGEN N.V.
17.25. Singular Genomics Systems, Inc.
17.26. Takara Bio Inc.
17.27. Tecan Trading AG
17.28. Thermo Fisher Scientific Inc.
17.29. Twist Bioscience Corporation
List of Figures
FIGURE 1. GLOBAL TARGETED SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL TARGETED SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL TARGETED SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES TARGETED SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA TARGETED SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TARGETED SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON-BASED KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON-BASED KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON-BASED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP-BASED KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP-BASED KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP-BASED KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY UMI-BASED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY UMI-BASED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY UMI-BASED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BAITS-BASED CAPTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BAITS-BASED CAPTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BAITS-BASED CAPTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PROBE-BASED CAPTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PROBE-BASED CAPTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PROBE-BASED CAPTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP PROBES FOR CNV ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP PROBES FOR CNV ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP PROBES FOR CNV ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP PROBES FOR SNP DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP PROBES FOR SNP DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MIP PROBES FOR SNP DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY POINT-OF-CARE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY UNITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY UNITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACOGENOMIC BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACOGENOMIC BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACOGENOMIC BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PREDICTIVE BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY RARE DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY RARE DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY RARE DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ANTIBIOTIC RESISTANCE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ANTIBIOTIC RESISTANCE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ANTIBIOTIC RESISTANCE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PATHOGEN DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PATHOGEN DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PATHOGEN DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PROGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PROGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PROGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY THERANOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY THERANOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY THERANOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 204. EUROPE TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. EUROPE TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. EUROPE TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 207. EUROPE TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 208. EUROPE TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 209. EUROPE TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 210. EUROPE TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 211. EUROPE TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 212. EUROPE TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 213. EUROPE TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. EUROPE TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 215. EUROPE TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 216. EUROPE TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. EUROPE TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 218. EUROPE TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 219. EUROPE TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 220. EUROPE TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 235. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 236. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 237. MIDDLE EAST TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 238. AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. AFRICA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. AFRICA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 241. AFRICA TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 242. AFRICA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 243. AFRICA TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 244. AFRICA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 245. AFRICA TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 246. AFRICA TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 247. AFRICA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. AFRICA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 249. AFRICA TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 250. AFRICA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. AFRICA TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 252. AFRICA TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 253. AFRICA TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 254. AFRICA TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 263. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 264. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 266. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 267. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 268. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 269. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 270. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 271. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 272. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 273. ASEAN TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. ASEAN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 275. ASEAN TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 276. ASEAN TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 277. ASEAN TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 278. ASEAN TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 279. ASEAN TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 280. ASEAN TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 281. ASEAN TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 282. ASEAN TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. ASEAN TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 284. ASEAN TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 285. ASEAN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 286. ASEAN TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 287. ASEAN TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 288. ASEAN TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 289. ASEAN TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 290. GCC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. GCC TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 292. GCC TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 293. GCC TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 294. GCC TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 295. GCC TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 296. GCC TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 297. GCC TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 298. GCC TARGETED SEQUENCING MARKET SIZE, BY MOLECULAR INVERSION PROBES, 2018-2032 (USD MILLION)
TABLE 299. GCC TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. GCC TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
TABLE 301. GCC TARGETED SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 302. GCC TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 303. GCC TARGETED SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 304. GCC TARGETED SEQUENCING MARKET SIZE, BY GENETIC DISEASES, 2018-2032 (USD MILLION)
TABLE 305. GCC TARGETED SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 306. GCC TARGETED SEQUENCING MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 307. EUROPEAN UNION TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION TARGETED SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION TARGETED SEQUENCING MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 312. EUROPEAN UNION TARGETED SEQUENCING MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION TARGETED SEQUENCING MARKET SIZE, BY HYBRID CAPTURE, 2018-2032 (USD MILLION)
TABLE 315. EURO

Companies Mentioned

The key companies profiled in this Targeted Sequencing market report include:
  • 10x Genomics, Inc.
  • A-Alpha Bio, Inc.
  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • DH Life Sciences, LLC
  • Element Biosciences
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Macrogen, Inc.
  • MGI Tech Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Paragon Genomics, Inc.
  • PerkinElmer, Inc.
  • Psomagen, Inc.
  • QIAGEN N.V.
  • Singular Genomics Systems, Inc.
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.1 Billion
Forecasted Market Value ( USD ) by 2032 $ 34.97 Billion
Compound Annual Growth Rate21.0%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Targeted Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Targeted Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Targeted Sequencing and Resequencing Market - Global Strategic Business Report - Product Image

Targeted Sequencing and Resequencing Market - Global Strategic Business Report

  • Report
  • 468 Pages
  • Global
From
Targeted Sequencing and Resequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Targeted Sequencing and Resequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Genomic Biomarker Market - Global Forecast 2026-2032 - Product Image

Genomic Biomarker Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
DNA Sequencing Market - Global Forecast 2026-2032 - Product Image

DNA Sequencing Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From

About the Targeted Sequencing Market

Targeted sequencing is a type of genomics technology that focuses on specific regions of the genome. It is used to identify genetic variants associated with diseases, to detect mutations in cancer, and to study gene expression. Targeted sequencing is a cost-effective alternative to whole-genome sequencing, as it requires less sequencing and data analysis. It is also used in clinical diagnostics, drug discovery, and agricultural research. Targeted sequencing is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.